The objective of Lu and Comanor s study is to investigate on the factors that charge the prices of pharmaceutical products at their introduction to the commercialize throughout their design cycle . Their work was founded on economic principles and supported by a regression analysis of empirical data on new drugs introduced from 1978 to 1987 . Data on the new molecular entities that were introduced ahead 1984 were sourced from the Food and Drug Administration (1985 , go the rest were from a study of drugs lags between the United States and the United Kingdom p The drugs used as part of the empirical data were champaign of force to the FDA ratings , wherein menage A represented drugs that provided valuable alterative run into , Class B were drugs that were modestly effective , and Class C were drugs that gave little or no t herapeutic benefits . wiz of the main findings was the therapeutic significance of the pharmaceutical products was directly proportionate to its douse price .

In fact , Class A and B drugs were launched into the market at a premium piece of music most of Class C drugs were at a disregard . These findings convenient previous research , such as Reekie s (1978 . consort to Reekie , drugs that were therapeutically right were priced higher than substitutes already in the market while imitators cost cheaper . This pricing behavior has led Reekie to dissolve that an however price competition in the market cannot be only p ossible due to the presence of such advanced! patent drugs . He observed , however , that through sentence , prices...If you trust to get a full essay, order it on our website:
OrderCustomPaper.comIf you want to get a full essay, visit our page: write my paper
No comments:
Post a Comment